The accurate identification of active sites in proteins is essential for the advancement of life sciences and pharmaceutical development, as these sites are of critical importance for enzyme activity and drug design. Recent advancements in protein language models (PLMs), trained on extensive datasets of amino acid sequences, have significantly improved our understanding of proteins. However, compared to the abundant protein sequence data, functional annotations, especially precise per-residue annotations, are scarce, which limits the performance of PLMs. On the other hand, textual descriptions of proteins, which could be annotated by human experts or a pretrained protein sequence-to-text model, provide meaningful context that could assist in the functional annotations, such as the localization of active sites. This motivates us to construct a $\textbf{ProT}$ein-$\textbf{A}$ttribute text $\textbf{D}$ataset ($\textbf{ProTAD}$), comprising over 570,000 pairs of protein sequences and multi-attribute textual descriptions.

Spatiotemporal data mining (STDM) has a wide range of applications in various complex physical systems (CPS), i.e., transportation, manufacturing, healthcare, etc. Among all the proposed methods, the Convolutional Long Short-Term Memory (ConvLSTM) has proved to be generalizable and extendable in different applications and has multiple variants achieving state-of-the-art performance in various STDM applications. However, ConvLSTM and its variants are computationally expensive, which makes them inapplicable in edge devices with limited computational resources. With the emerging need for edge computing in CPS, efficient AI is essential to reduce the computational cost while preserving the model performance. Common methods of efficient AI are developed to reduce redundancy in model capacity (i.e., model pruning, compression, etc.). However, spatiotemporal data mining naturally requires extensive model capacity, as the embedded dependencies in spatiotemporal data are complex and hard to capture, which limits the model redundancy. Instead, there is a fairly high level of data and feature redundancy that introduces an unnecessary computational burden, which has been largely overlooked in existing research. Therefore, we developed a novel framework SparseST, that pioneered in exploiting data sparsity to develop an efficient spatiotemporal model. In addition, we explore and approximate the Pareto front between model performance and computational efficiency by designing a multi-objective composite loss function, which provides a practical guide for practitioners to adjust the model according to computational resource constraints and the performance requirements of downstream tasks.

MMSite is a two-stage ("First Align, Then Fuse") Understanding these sites is essential for elucidating enzyme mechanisms, designing inhibitors, and developing novel drugs. MNER, high-quality datasets for multi-modal active sites identification are less abundant.

The accurate identification of active sites in proteins is essential for the advancement of life sciences and pharmaceutical development, as these sites are of critical importance for enzyme activity and drug design. Recent advancements in protein language models (PLMs), trained on extensive datasets of amino acid sequences, have significantly improved our understanding of proteins. However, compared to the abundant protein sequence data, functional annotations, especially precise per-residue annotations, are scarce, which limits the performance of PLMs. On the other hand, textual descriptions of proteins, which could be annotated by human experts or a pretrained protein sequence-to-text model, provide meaningful context that could assist in the functional annotations, such as the localization of active sites. Based on this dataset, we propose \textbf{MMSite}, a multi-modal framework that improves the performance of PLMs to identify active sites by leveraging biomedical language models (BLMs).

Enzyme-catalyzed protein cleavage is essential for many biological functions. Accurate prediction of cleavage sites can facilitate various applications such as drug development, enzyme design, and a deeper understanding of biological mechanisms. However, most existing models are restricted to an individual enzyme, which neglects shared knowledge of enzymes and fails generalize to novel enzymes. Thus, we introduce a unified protein cleavage site predictor named UniZyme, which can generalize across diverse enzymes. To enhance the enzyme encoding for the protein cleavage site prediction, UniZyme employs a novel biochemically-informed model architecture along with active-site knowledge of proteolytic enzymes. Extensive experiments demonstrate that UniZyme achieves high accuracy in predicting cleavage sites across a range of proteolytic enzymes, including unseen enzymes. The code is available in https://anonymous.4open.science/r/UniZyme-4A67.

Predicting multiple functions labeled with Enzyme Commission (EC) numbers from the enzyme sequence is of great significance but remains a challenge due to its sparse multi-label classification nature, i.e., each enzyme is typically associated with only a few labels out of more than 6000 possible EC numbers. However, existing machine learning algorithms generally learn a fixed global representation for each enzyme to classify all functions, thereby they lack interpretability and the fine-grained information of some function-specific local residue fragments may be overwhelmed. Here we present an attention-based framework, namely ProtDETR (Protein Detection Transformer), by casting enzyme function prediction as a detection problem. It uses a set of learnable functional queries to adaptatively extract different local representations from the sequence of residue-level features for predicting different EC numbers. ProtDETR not only significantly outperforms existing deep learning-based enzyme function prediction methods, but also provides a new interpretable perspective on automatically detecting different local regions for identifying different functions through cross-attentions between queries and residue-level features. The development of genome sequencing technologies has unveiled a vast collection of protein sequences, but detailed functional annotations are only available for a very small number of them [2]. Evaluating the functions of protein sequences via wet experiments is time-consuming, labor-intensive, and expensive, underscoring the critical need for computational methods to predict protein functions. This is particularly acute in the study of enzymes, which catalyze various biological reactions and are central to understanding metabolic processes. For the most widely-used EC number classification scheme, each class of enzyme function is assigned an EC number, which is a four-level hierarchy reflecting the intricate organization of enzyme functions.

Traditional drug design faces significant challenges due to inherent chemical and biological complexities, often resulting in high failure rates in clinical trials. Deep learning advancements, particularly generative models, offer potential solutions to these challenges. One promising algorithm is DrugGPT, a transformer-based model, that generates small molecules for input protein sequences. Although promising, it generates both chemically valid and invalid structures and does not incorporate the features of approved drugs, resulting in time-consuming and inefficient drug discovery. To address these issues, we introduce DrugGen, an enhanced model based on the DrugGPT structure. DrugGen is fine-tuned on approved drug-target interactions and optimized with proximal policy optimization. By giving reward feedback from protein-ligand binding affinity prediction using pre-trained transformers (PLAPT) and a customized invalid structure assessor, DrugGen significantly improves performance. Evaluation across multiple targets demonstrated that DrugGen achieves 100% valid structure generation compared to 95.5% with DrugGPT and produced molecules with higher predicted binding affinities (7.22 [6.30-8.07]) compared to DrugGPT (5.81 [4.97-6.63]) while maintaining diversity and novelty. Docking simulations further validate its ability to generate molecules targeting binding sites effectively. For example, in the case of fatty acid-binding protein 5 (FABP5), DrugGen generated molecules with superior docking scores (FABP5/11, -9.537 and FABP5/5, -8.399) compared to the reference molecule (Palmitic acid, -6.177). Beyond lead compound generation, DrugGen also shows potential for drug repositioning and creating novel pharmacophores for existing targets. By producing high-quality small molecules, DrugGen provides a high-performance medium for advancing pharmaceutical research and drug discovery.

Recent progress in Graph Neural Networks (GNNs) has greatly enhanced the ability to model complex molecular structures for predicting properties. Nevertheless, molecular data encompasses more than just graph structures, including textual and visual information that GNNs do not handle well. To bridge this gap, we present an innovative framework that utilizes multimodal molecular data to extract insights from Large Language Models (LLMs). We introduce GALLON (Graph Learning from Large Language Model Distillation), a framework that synergizes the capabilities of LLMs and GNNs by distilling multimodal knowledge into a unified Multilayer Perceptron (MLP). This method integrates the rich textual and visual data of molecules with the structural analysis power of GNNs. Extensive experiments reveal that our distilled MLP model notably improves the accuracy and efficiency of molecular property predictions.

Here, we report the implementation and application of a simple, structure-aware framework to generate target-specific screening libraries. Our approach combines advances in generative artificial intelligence (AI) with conventional molecular docking to explore chemical space conditioned on the unique physicochemical properties of the active site of a biomolecular target. As a demonstration, we used our framework, which we refer to as sample-and-dock, to construct focused libraries for cyclin-dependent kinase type-2 (CDK2) and the active site of the main protease (Mpro) of the SARS-CoV-2 virus. We envision that the sample-and-dock framework could be used to generate theoretical maps of the chemical space specific to a given target and so provide information about its molecular recognition characteristics.